BAY 2927088 (Sevabertinib)
Product Specifications
CAS Number
2521285-05-0
Synonyms
Sevabertinib
Target
Others
Applications
Others
Molecular Formula
C24H25ClN4O5
Additionnal Information
BAY 2927088 (Sevabertinib) is the first non-covalent, potent, oral, selective, and reversible inhibitor of tyrosine kinase that potently inhibits mutant HER2 and mutant EGFR in preclinical models. It targets Exon 20 insertions in non-small-cell lung carcinoma (NSCLC) patients.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470204-500 1x 500 µL
Complement C4d (C4D204), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680818-100 1x 100 µL
CD45RA (PTPRC/818), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740914-500 1x 500 µL
NGFR (Nerve Growth Factor Receptor) (NGFR5 + NTR/912), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details